Jordan AS, McSharry DG, Malhotra A (2014) Adult obstructive sleep apnoea. Lancet 383(9918):736–747

Article  PubMed  Google Scholar 

Song SO et al (2019) Metabolic consequences of obstructive sleep apnea especially pertaining to diabetes mellitus and insulin sensitivity. Diabetes Metab J 43(2):144–155

Article  PubMed  PubMed Central  Google Scholar 

Koh HE et al (2022) Effect of obstructive sleep apnea on glucose metabolism. Eur J Endocrinol 186(4):457–467

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y et al (2022) Genetic determinants of cardiometabolic and pulmonary phenotypes and obstructive sleep apnoea in HCHS/SOL. EBioMedicine 84:104288

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reutrakul S, Mokhlesi B (2017) Obstructive sleep apnea and diabetes: a state of the art review. Chest 152(5):1070–1086

Article  PubMed  PubMed Central  Google Scholar 

Tatsumi K et al (2005) Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 127(3):716–721

Article  PubMed  Google Scholar 

Münzberg H et al (2005) Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 62(6):642–652

Article  PubMed  Google Scholar 

Messenger SA, Moreau JM, Ciriello J (2013) Effect of chronic intermittent hypoxia on leptin and leptin receptor protein expression in the carotid body. Brain Res 1513:51–60

Article  CAS  PubMed  Google Scholar 

Conde SV et al (2017) Insulin resistance: a new consequence of altered carotid body chemoreflex? J Physiol 595(1):31–41

Article  CAS  PubMed  Google Scholar 

Aurora RN, Punjabi NM (2013) Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association. Lancet Respir Med 1(4):329–338

Article  PubMed  Google Scholar 

Roden M et al (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97(12):2859–2865

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santomauro AT et al (1999) Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48(9):1836–1841

Article  CAS  PubMed  Google Scholar 

Hücking K et al (2003) Burst-like control of lipolysis by the sympathetic nervous system in vivo. J Clin Invest 111(2):257–264

Article  PubMed  PubMed Central  Google Scholar 

Julius S et al (1992) The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Press 1(1):9–19

Article  CAS  PubMed  Google Scholar 

Jamerson KA et al (1993) Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21(5):618–623

Article  CAS  PubMed  Google Scholar 

Punjabi NM, Polotsky VY (2005) Disorders of glucose metabolism in sleep apnea. J Appl Physiol (1985) 99(5):1998–2007

Article  CAS  PubMed  Google Scholar 

Kent BD, McNicholas WT, Ryan S (2015) Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea. J Thorac Dis 7(8):1343–1357

PubMed  PubMed Central  Google Scholar 

Lavie L (2012) Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci (Elite Ed) 4(4):1391–1403

Article  MathSciNet  PubMed  Google Scholar 

Newsholme P et al (2019) Oxidative stress pathways in pancreatic β-cells and insulin-sensitive cells and tissues: importance to cell metabolism, function, and dysfunction. Am J Physiol Cell Physiol 317(3):C420-c433

Article  CAS  PubMed  Google Scholar 

Penev PD (2012) Update on energy homeostasis and insufficient sleep. J Clin Endocrinol Metab 97(6):1792–1801

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shechter A (2017) Obstructive sleep apnea and energy balance regulation: a systematic review. Sleep Med Rev 34:59–69

Article  PubMed  Google Scholar 

Bottini P et al (2008) Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics. Respiration 75(3):265–271

Article  PubMed  Google Scholar 

Bottini P et al (2003) Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J 22(4):654–660

Article  CAS  PubMed  Google Scholar 

Tahrani AA et al (2012) Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. Am J Respir Crit Care Med 186(5):434–441

Article  PubMed  PubMed Central  Google Scholar 

Adderley NJ et al (2020) Obstructive sleep apnea, a risk factor for cardiovascular and microvascular disease in patients with type 2 diabetes: findings from a population-based cohort study. Diabetes Care 43(8):1868–1877

Article  PubMed  Google Scholar 

Lin R et al (2022) Positive airway pressure therapy in heart failure patients comorbid with obstructive sleep apnea: Cardiovascular outcomes and nighttime-duration effect. Eur J Clin Invest 52(10):e13821

Article  CAS  PubMed  Google Scholar 

Lin R et al (2023) Effect of different anti-cardiovascular disease treatments on the severity of obstructive sleep apnea. J Sleep Res

Mokhlesi B et al (2017) Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profiles of glucose, insulin and counter-regulatory hormones in type 2 diabetes. Diabetes Obes Metab 19(3):452–456

Article  CAS  PubMed  Google Scholar 

Simera I et al (2010) A catalogue of reporting guidelines for health research. Eur J Clin Invest 40(1):35–53

Article  CAS  PubMed  Google Scholar 

Makris K, Spanou L (2011) Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol 5(6):1572–1583

Article  PubMed  PubMed Central  Google Scholar 

Jadad AR et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12

Article  CAS  PubMed  Google Scholar 

Wells G et al (2009) The Newcastle–Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. [cited 2009 2009–10–19.; Available from: http://www.ohrica/programs/clinical_epidemiology/oxfordasp

Richardson M, Garner P, Donegan S (2019) Interpretation of subgroup analyses in systematic reviews: a tutorial. Clin Epidemiol Global Health 7(2):192–198

Article  Google Scholar 

Tsapas A et al (2020) Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis. Ann Intern Med 173(4):278–286

Article  PubMed  Google Scholar 

Mason M, Welsh EJ and Smith I (2013) Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev (5):Cd003002

Zhang J et al (2017) Therapeutic effects of different drugs on obstructive sleep apnea/hypopnea syndrome in children. World J Pediatr 13(6):537–543

Article  CAS  PubMed  Google Scholar 

Scheen AJ (2015) Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus. Drugs 75(1):33–59

Article  CAS  PubMed  Google Scholar 

Heerspink HJ et al (2016) Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications. Circulation 134(10):752–772

Article  CAS  PubMed  Google Scholar 

Yang D et al (2013) Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 17(1):33–38

Article  PubMed  Google Scholar 

Tsapas A et al (2021) Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetes Obes Metab 23(9):2116–2124

Article  CAS  PubMed  Google Scholar 

Blackman A et al (2014) Liraglutide 3.0 mg reduces severity of obstructive sleep apnoea and body weight in obese individuals with moderate or severe disease: SCALE sleep apnoea trial. Diabetologia 57(1 SUPPL. 1):S85

Google Scholar 

Yazıcı D et al (2023) Clinical impact of glucagon-like peptide-1 receptor analogs on the complications of obesity. Obes Facts 16(2):149–163

Article  PubMed